Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The ...

Key Takeaway: NEW BRUNSWICK, N.J. , Aug. 29, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2019 Morgan Stanley 17 th Annual Global Healthcare Conference on Tuesday, September 10 th , at The Grand Hyatt Hotel in New York. Peter F. Lebowitz , M.D., Ph.D. Global Ther

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Aug. 29, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2019 Morgan Stanley 17 th Annual Global Healthcare Conference on Tuesday, September 10 th , at The Grand Hyatt Hotel in New York. Peter F. Lebowitz , M.D., Ph.D. Global Therapeutic Area Head, Oncology and Scott White , Company Group Chairman North America Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Last updated: Aug 29, 2019